SEC Filing Details

Document Details

Form
Filing Date
Nov 14, 2022
Document Date
Jul 20, 2022
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Theravance Biopharma
Issuer
Theravance Biopharma, Inc.

Shareholder Tools